↓ Skip to main content

Dove Medical Press

Lanadelumab Injection Treatment For The Prevention Of Hereditary Angioedema (HAE): Design, Development And Place In Therapy

Overview of attention for article published in Drug Design, Development and Therapy, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
9 patents

Readers on

mendeley
37 Mendeley
Title
Lanadelumab Injection Treatment For The Prevention Of Hereditary Angioedema (HAE): Design, Development And Place In Therapy
Published in
Drug Design, Development and Therapy, October 2019
DOI 10.2147/dddt.s192475
Pubmed ID
Authors

Maria Bova, Anna Valerieva, Maddalena Alessandra Wu, Riccardo Senter, Francesca Perego

Timeline
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 16%
Professor 3 8%
Researcher 3 8%
Student > Ph. D. Student 3 8%
Student > Doctoral Student 2 5%
Other 4 11%
Unknown 16 43%
Readers by discipline Count As %
Medicine and Dentistry 8 22%
Biochemistry, Genetics and Molecular Biology 3 8%
Immunology and Microbiology 2 5%
Nursing and Health Professions 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 8%
Unknown 19 51%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2024.
All research outputs
#5,750,900
of 26,460,266 outputs
Outputs from Drug Design, Development and Therapy
#401
of 2,310 outputs
Outputs of similar age
#103,659
of 366,141 outputs
Outputs of similar age from Drug Design, Development and Therapy
#7
of 29 outputs
Altmetric has tracked 26,460,266 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,310 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,141 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.